MedTrace Logo

Letrozole Pretreatment With Misoprostol for Second-Trimester Medical Abortion

NCT02405156 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2017-01-26

No results posted yet for this study

Summary

To compare the success rate of letrozole and misoprostol versus misoprostol alone for medical termination of pregnancy in second trimester abortion.

Conditions

  • Miscarriage

Interventions

DRUG

Letrozole

DRUG

Placebo

DRUG

Misoprostol

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mostafa Gomaa, MD · Ain Shams University

  • Ihab Serag-ElDin, MD · Ain Shams University

  • Gasser El-Bishry, FRCOG · Ain Shams University

  • Ahmed Swidan, M.B.B.ch · Ain Shams University

  • Mohamed S. Sweed, MD · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02405156 on ClinicalTrials.gov